fda warning letters glp-1 compounders september 2025 news takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA and Novo Nordisk Warned

BPC-157 Supports Vascular and Neurological Repair One underappreciated hallmark of long COVID is endothelial dysfunction damage to the lining of blood vessels that impairs circulation, oxygenation, and tissue delivery.7 BPC-157 has demonstrated angiogenic (new blood vessel formation) effects in research models, upregulating VEGFR2 and promoting collateral circulation in ischemic tissue.8 This matters for two reasons: Cardiovascular symptoms (breathlessness, reduced exercise tolerance, tachycardia) may partly reflect impaired tissue oxygenation from vascular damage Neurological symptoms (brain fog, cognitive impairment) may similarly reflect reduced cerebral blood flow BPC-157's neuroprotective effects shown across models of traumatic brain injury, dopamine dysregulation, and serotonin syndrome also suggest value in supporting the neurotransmitter disruption many long COVID patients experience.9 BPC-157 Modulates Inflammation Without Immune Suppression This is critical

Mechanism of action, what it does at the cellular level AOD-9604 is special in one regard: it has no clearly identified target receptor

I went with Retatrutide as my main compound because the triple-action thing made sense to me once I read how it works

Semaglutide (oral route)